MRNA Stock Recent News
MRNA LATEST HEADLINES
Moderna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous trading session.
Investors have worried about Moderna's growth prospects as demand for its coronavirus vaccine declines. Moderna may have a new billion-dollar product right around the corner.
Covid vaccine maker Moderna Inc and partner Merck Sharp and Dohme (MSD) have initiated a phase III trial in the UK for the world's first "personalised" mRNA vaccine, mRNA-4157 (V940), targeting melanoma, the deadliest form of skin cancer. Tailored to each patient's unique genetic tumour markers, the treatment aims to train the immune system to recognise and eliminate cancer cells, potentially preventing the cancer from returning.
While artificial intelligence may be useful for a variety of purposes – including asking silly questions we're afraid to pose in real life – the ultimate end game for digital intelligence could be to advance the human condition, which brings us to medical AI stocks. When conducted in a controlled environment, AI can help accelerate productivity.
Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday.
CAMBRIDGE, MA / ACCESSWIRE / April 17, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024 to report its first quarter 2024 financial results, and provide a corporate update.
Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
AI could solve one of the biggest problems in drug development: the lengthy time it takes to bring a product to market. The AI in healthcare market is set to expand at a compound annual growth rate of nearly 50%.
Moderna and Merck are collaborating on a personalized cancer vaccine. That vaccine program just disclosed some new data from the clinic.
Moderna (MRNA) closed the most recent trading day at $107.01, moving -0.12% from the previous trading session.